News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The 5 Highest-Priced Drugs: BioMarin Pharmaceutical Inc. (BMRN)'s $380,000 Latest Is Not Even Close To Top


2/20/2014 7:45:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BioMarin Pharmaceutical Inc. priced its latest rare disease drug Tuesday at $380,000 a year. But the most interesting thing about the price of Vimizim, the San Rafael-based drug developer's recently approved enzyme replacement therapy for people with Morquio A syndrome, is that BioMarin isn't even close to being No. 1. In fact, Vimizim would have to raise its price by more than $35,000 even to reach second place.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Business Times

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES